Corcept Therapeutics Incorporated (CORT)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 840,553 | 621,517 | 583,430 | 423,756 | 571,731 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $840,553K
= 0.00
Corcept Therapeutics Incorporated has consistently maintained a debt-to-assets ratio of 0.00 over the five-year period from December 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt financing to fund its operations and investments during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets are entirely financed by equity, which may indicate a strong financial position and lower financial risk. However, it is important to note that a low debt-to-assets ratio may also indicate a missed opportunity to take advantage of financial leverage for potential growth opportunities. Overall, Corcept Therapeutics' consistent 0.00 debt-to-assets ratio signifies a conservative capital structure strategy during the period under review.
Peer comparison
Dec 31, 2024